Bacterial Resistance
in the News
CDC: Deadly, drug-defying CRE bacteria on rise in U.S. hospitals
‘We Have a Limited Window of Opportunity’: CDC Warns of Resistance ‘Nightmare’
Recent Achaogen News
Achaogen Awarded $60M Contract Option by BARDA for the Clinical Development of Plazomicin
PUBLICATIONS/POSTERS
The pharmacokinetics (PK) and safety of plazomicin in subjects with renal impairment
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
George G Zhanel, Christopher D Lawson, Sheryl Zelenitsky, Brandon Findlay, Frank Schweizer, Heather Adam, Andrew Walkty, Ethan Rubinstein, Alfred S Gin, Daryl J Hoban, Joseph P Lynch and James A Karlowsky
Expert Review of Anti-infective Therapy. April 2012, Vol. 10, No. 4, Pages 459-473 , DOI 10.1586/eri.12.25
Access this publication at expert-reviews.com [purchase or paid subscription required]
© Achaogen, Inc. 2004-2013. All rights reserved. Privacy Policy | Terms of Use
